101 related articles for article (PubMed ID: 8150540)
1. Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer.
Süsal C; Maier H; Lorenz K; Opelz G
Int J Cancer; 1994 Apr; 57(1):47-50. PubMed ID: 8150540
[TBL] [Abstract][Full Text] [Related]
2. [Illness stage and IgA-anti-Fab/F(ab')2 autoantibody activity in serum of patients with malignant head-neck tumors].
Lorenz KJ; Süsal C; Opelz G; Maier H
Laryngorhinootologie; 1996 Dec; 75(12):764-8. PubMed ID: 9081283
[TBL] [Abstract][Full Text] [Related]
3. Relationship between progression of disease and immunoglobulin A-anti-Fab-/F(ab')2 autoantibodies in patients with head and neck cancer.
Lorenz KJ; Süsal C; Opelz G; Maier H
Otolaryngol Head Neck Surg; 1998 Jan; 118(1):130-6. PubMed ID: 9450843
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival.
Süsal C; Dörr C; Groth J; May G; Opelz G
Transpl Int; 1994; 7 Suppl 1():S586-9. PubMed ID: 11271315
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune component in individuals during immune response to inactivated combined vaccine against Q fever.
Krutitskaya L; Tokarevich N; Zhebrun A; Kartseva N; Tarasevich I; Yablonskaya V; Fatalieva S; Misnikov OP; Vasilenko AZ
Acta Virol; 1996 Sep; 40(4):173-7. PubMed ID: 9014006
[TBL] [Abstract][Full Text] [Related]
6. Different appearance and pathogenic roles of serum IgA against autologous IgG Fc and Fab in patients with IgA nephropathy.
Yashiro M; Muso E; Yoshida H; Shimada T; Matsushima M; Sawanishi K; Sugiyama T; Kawai C
Nihon Jinzo Gakkai Shi; 1991 May; 33(5):497-506. PubMed ID: 1895549
[TBL] [Abstract][Full Text] [Related]
7. Anti-p53 antibodies in serum of smokers and head and neck cancer patients.
Wollenberg B; Jan NV; Pitzke P; Reiter W; Stieber P
Anticancer Res; 1997; 17(1A):413-8. PubMed ID: 9066686
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study.
Kim MS; Kim YS; Kim SI; Lee JW; Moon JI; Park K
Transplant Proc; 1998 Nov; 30(7):2977-8. PubMed ID: 9838314
[No Abstract] [Full Text] [Related]
9. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
[TBL] [Abstract][Full Text] [Related]
10. Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants. The Collaborative Transplant Study.
Süsal C; Döhler B; Opelz G
Transplantation; 2000 Apr; 69(7):1337-40. PubMed ID: 10798750
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin levels in patients with head and neck cancer (IgE, IgA, IgM, IgG).
Vinzenz K; Pavelka R; Schönthal E; Zekert F
Oncology; 1986; 43(5):316-22. PubMed ID: 3763126
[TBL] [Abstract][Full Text] [Related]
12. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity.
Süsal C; Wiesel M; Staehler G; Groth J; May G; Opelz G
Transplant Proc; 1995 Feb; 27(1):1072-4. PubMed ID: 7878810
[No Abstract] [Full Text] [Related]
13. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
[TBL] [Abstract][Full Text] [Related]
14. [Serum and salivary immunoglobulin A levels in patients with cancer of the mouth and oropharynx].
de Souza RM; Lehn CN; Denardin OV
Rev Assoc Med Bras (1992); 2003; 49(1):40-4. PubMed ID: 12724811
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of anti-Fab antibodies in patients with autoimmune and infectious diseases.
Hassan J; Feighery C; Bresnihan B; Whelan A
Clin Exp Immunol; 1992 Sep; 89(3):423-6. PubMed ID: 1516258
[TBL] [Abstract][Full Text] [Related]
16. IgA-anti-Fab autoantibodies and disease progression in AIDS.
Süsal C; Daniel V; Doerr C; Zimmermann R; Huth-Kühne A; Opelz G
Immunol Lett; 1993 Apr; 36(1):27-30. PubMed ID: 8102124
[TBL] [Abstract][Full Text] [Related]
17. Aberrant synthesis of antibodies directed at the Fab fragment of IgA in patients with IgA nephropathies.
Jackson S; Montgomery RI; Julian BA; Galla JH; Czerkinsky C
Clin Immunol Immunopathol; 1987 Nov; 45(2):208-13. PubMed ID: 3499275
[TBL] [Abstract][Full Text] [Related]
18. Autoimmunity to the M(r) 32,000 subunit of replication protein A in breast cancer.
Tomkiel JE; Alansari H; Tang N; Virgin JB; Yang X; VandeVord P; Karvonen RL; Granda JL; Kraut MJ; Ensley JF; Fernández-Madrid F
Clin Cancer Res; 2002 Mar; 8(3):752-8. PubMed ID: 11895905
[TBL] [Abstract][Full Text] [Related]
19. Treatment-induced changes of lymphocyte subsets in patients with adenoid cystic carcinoma of the head and neck.
Jeske SS; Weissinger SE; Veit JA; Brunner C; Huber U; Theodoraki MN; Hoffmann TK; Schuler PJ; Doescher J
Eur Arch Otorhinolaryngol; 2019 May; 276(5):1465-1473. PubMed ID: 30815724
[TBL] [Abstract][Full Text] [Related]
20. Normal human sera contain antibodies directed at Fab of IgA.
Jackson S; Montgomery RI; Mestecky J; Czerkinsky C
J Immunol; 1987 Apr; 138(7):2244-8. PubMed ID: 3494062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
